Cart
sales@molnova.com
Bromotriazine
CAS No. ——
Bromotriazine( BTZ )
Catalog No. M17054 CAS No. ——
Bromotriazine (BTZ) is a covalent probe against bromodomain containing proteins.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBromotriazine
-
NoteResearch use only, not for human use.
-
Brief DescriptionBromotriazine (BTZ) is a covalent probe against bromodomain containing proteins.
-
DescriptionBromotriazine (BTZ) is a covalent probe against bromodomain containing proteins with selectively targeting non-catalytic, highly conserved amino acid residues.
-
In Vitro——
-
In Vivo——
-
SynonymsBTZ
-
PathwayChromatin/Epigenetic
-
TargetBromodomain
-
RecptorBromodomain
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight498.328
-
Molecular FormulaC21H17Cl2N9O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Namebut-3-yn-1-yl (6-(3-((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-methylphenyl)-3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-yl)carbamate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. D'Ascenzio M, et al. Angew Chem Int Ed Engl. 2018 Dec 27. doi: 10.1002/anie.201807825.
molnova catalog
related products
-
RVX2135
RVX2135 is a novel potent and orally bioavailable inhibitor of Brd2, Brd3, Brd4, and BrdT.
-
INCB054329
INCB054329 is a novel potent, orally bioactive BET inhibitor that inhibits binding of BRD2, BRD3 and BRD4 to an acetylated histone H4 peptide with low nanomolar potency.
-
MS-417
MS-417 (GTPL-7512) is a highly specific BET bromodomain inhibitor that binds to BRD4-BD1 and BRD4 BD2 with Kd of 36.1 uM and 25.4 uM respectively.
